Charles River Laboratories CRL Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Net margin | -4.6%-1.0pp | -3.6%— | —— | —— | —— | |
| EBITDA margin | 17.5%-0.2pp | 17.7%-1.9pp | 19.6%+0.4pp | 19.2%-0.5pp | 19.7%-0.3pp | |
| Free cash flow margin | 9.7%-3.2pp | 12.9%-0.6pp | 13.5%-0.8pp | 14.4%+0.4pp | 14%+1.6pp | |
| Returns | ||||||
| Return on equity | -6%-1.7pp | -4.4%— | —— | —— | —— | |
| Return on assets | -2.4%-0.4pp | -2%— | —— | —— | —— | |
| Return on invested capital | 6%+0.7pp | 5.3%-0.6pp | 5.9%+0.3pp | 5.5%+2.4pp | 3.2%-0.4pp | |
| Efficiency | ||||||
| Asset turnover | 0.5×0.0× | 0.5×0.0× | 0.5×0.0× | 0.5×0.0× | 0.5×0.0× | |
| Liquidity | ||||||
| Current ratio | 1.4×+0.1× | 1.3×-0.1× | 1.4×0.0× | 1.4×-0.1× | 1.4×0.0× | |
| Quick ratio | 1×0.0× | 1×-0.1× | 1.1×0.0× | 1.1×-0.1× | 1.2×0.0× | |
| Cash ratio | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | |
| Leverage | ||||||
| Debt-to-equity | 1×+0.2× | 0.8×+0.1× | 0.8×-0.1× | 0.8×-0.1× | 0.9×+0.1× | |
| Debt-to-assets | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | |
| Net debt / EBITDA | 4.1×+0.7× | 3.4×+0.3× | 3.1×-0.3× | 3.4×-0.1× | 3.5×+0.3× | |
| Interest coverage | 3.3×+0.5× | 2.9×-0.4× | 3.2×+0.3× | 3×-0.4× | 3.3×-0.2× | |
| Per Share | ||||||
| Book value per share | $60.07-5.9% | $63.85-7.3% | $68.90+1.3% | $68.00+8.2% | $62.82-6.3% | |
| Valuation | ||||||
| Market capitalization | $8.49B-13.5% | $9.82B+27.5% | $7.7B+5.6% | $7.29B-5.3% | $7.7B-18.5% | |
| Enterprise value | $11.37B-7.3% | $12.26B+20.8% | $10.15B+2.3% | $9.92B-5.4% | $10.48B-13.0% | |
| Price / sales | 2.1×-0.3× | 2.4×+0.5× | 1.9×+0.1× | 1.8×-0.1× | 1.9×-0.4× | |
| Price / book | 2.9×-0.2× | 3.1×+0.8× | 2.3×+0.1× | 2.2×-0.2× | 2.4×-0.3× | |
| EV / EBITDA | 16.2×-1.1× | 17.2×+4.4× | 12.9×+0.1× | 12.8×-0.4× | 13.2×-1.7× | |
| EV / sales | 2.8×-0.2× | 3.1×+0.5× | 2.5×+0.1× | 2.5×-0.1× | 2.6×-0.4× | |
| Free cash flow yield | 4.6%-0.7pp | 5.3%-1.8pp | 7.1%-0.9pp | 7.9%+0.6pp | 7.3%+2.0pp | |
| Earnings yield | -2.2%-0.7pp | -1.5%— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Charles River Laboratories's profit margins?
- Charles River Laboratories (CRL) runs a 84.7% gross margin and a 13.0% operating margin, with a -4.6% net margin.
- Where do Charles River Laboratories's ratios come from?
- Every ratio is computed from Charles River Laboratories's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
